Abiopharma

ADMA INVESTOR DEADLINE: ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

VolitionRx Announces Collaboration with Sysmex

Stratasys Advances Rail-Ready Additive Manufacturing With Certified Flame-Retardant FDM Material

Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform

Alpha Cash Regulatory Footprint Expands to Six States, Reaching an Estimated 2.4 Million Unbanked and Underbanked Households

ParaZero Receives Additional DefendAir Net Pod Order from Second Business Unit of Tier-1 Israeli-Based Global Defense Company

Smartbird Appoints New CEO to Advance AI Infrastructure Strategy

A New Press Release from Elicio Therapeutics

Ameresco Modernizes Energy Infrastructure Across Mount Sinai School District

IonQ Introduces Clavis XG Multiplex, Making Quantum Security Deployable at Scale in Metro Networks